The markets are set for a strong day after showings bullish trading activity in the early morning session. This follows data showing that despite the
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) traded up 51.66% after announcing the encouraging result of a Phase 3 trial evaluating its drug candidate ganaxolone
The markets are up this morning driven by a combination of COVID-19 vaccine excitement, and China-related news. On COVID-19 vaccine news, the announcement by AstraZeneca
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.